| Quarterly Financials | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
Revenue  | 54 | 116 | 103 | 116 | 126 | 116 | 114 | 119 | 107 | 124 | 117 | 126 | 127 | 146 | 138 | 159 | 160 | 188 | 174 | 179 | 195 | 208 |
| Expenses | 38 | 62 | 54 | 58 | 66 | 62 | 63 | 68 | 65 | 72 | 69 | 72 | 73 | 82 | 82 | 92 | 95 | 107 | 102 | 105 | 115 | 120 |
| EBITDA | 16 | 54 | 49 | 59 | 60 | 54 | 51 | 51 | 43 | 52 | 48 | 54 | 54 | 64 | 55 | 66 | 65 | 81 | 72 | 73 | 81 | 88 |
| Operating Profit % | 27 % | 45 % | 46 % | 49 % | 46 % | 45 % | 43 % | 41 % | 38 % | 40 % | 39 % | 41 % | 40 % | 41 % | 38 % | 41 % | 39 % | 42 % | 40 % | 39 % | 39 % | 41 % |
| Depreciation | 12 | 14 | 13 | 13 | 12 | 13 | 13 | 15 | 14 | 16 | 20 | 11 | 13 | 14 | 15 | 16 | 17 | 17 | 18 | 19 | 21 | 22 |
| Interest | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 7 | 7 | 8 | 8 |
| Profit Before Tax | 1 | 36 | 33 | 43 | 44 | 38 | 34 | 31 | 24 | 31 | 22 | 37 | 36 | 45 | 35 | 44 | 42 | 57 | 47 | 47 | 52 | 58 |
| Tax | -1 | 9 | 8 | 11 | 11 | 10 | 8 | 8 | 6 | 8 | 6 | 9 | 9 | 11 | 9 | 10 | 10 | 15 | 11 | 13 | 14 | 15 |
| Net Profit | 2 | 27 | 25 | 32 | 33 | 28 | 26 | 24 | 18 | 24 | 17 | 28 | 26 | 34 | 26 | 34 | 32 | 42 | 35 | 35 | 39 | 43 |
| EPS in ₹ | 3.55 | 2.59 | 2.43 | 3.08 | 3.23 | 2.72 | 2.48 | 2.33 | 1.71 | 2.29 | 1.60 | 2.69 | 2.57 | 3.26 | 2.53 | 3.27 | 3.06 | 4.10 | 3.42 | 3.38 | 3.76 | 4.21 |
Vijaya Diagnostic Centre
Vijaya Diagnostic Centre
1,025.00
-14.40
(-1.39%)
Key Fundamentals
Market Cap
10,677.20 Cr
EPS
13.95
PE Ratio
70.17
Dividend Yield
0.19 %
Industry
Healthcare Services 52 Week High
1,275.00
52 Week Low
740.00
PB Ratio
12.33
Debt to Equity
0.40
Sector
Healthcare Service Provider Analyst Rating and Forecast
- By Refinitiv from8 analysts
Actual
Company News
View All News
Vijaya Diagnostic Centre Limited announced the completion of its amalgamation with Medinova Diagnostic Services Limited following NCLT approval on October 13, 2025. The scheme became effective on November 4, 2025, resulting in the automatic dissolution of Medinova Diagnostic Services without winding-up. Under the share exchange ratio, Medinova shareholders will receive 1 equity share of face value INR 1 in Vijaya Diagnostic for every 22 equity shares of face value INR 10 held in Medinova. The company's authorized share capital increased to INR 230.5 crores divided into 230.5 crore equity shares of INR 1 each. Vijaya Diagnostic cancelled its investment of 62.02 lakh equity shares (62.14% stake) in Medinova. Through this amalgamation, Medinova Millennium MRI Services LLP, previously a wholly-owned subsidiary of Medinova, became a wholly-owned subsidiary of Vijaya Diagnostic. The MRI services entity operates in Kolkata with a turnover of approximately INR 2.36 crores in FY2024-25. The record date for determining eligible shareholders is November 25, 2025.
Vijaya Diagnostic Centre has established November 25, 2025, as the record date for share allotment. Under this arrangement, shareholders will receive 1 share in Vijaya Diagnostic Centre for every 22 shares held in Medinova. This share allotment affects existing Medinova shareholders who will become eligible for Vijaya Diagnostic Centre shares based on their holdings as of the record date.
Vijaya Diagnostic Centre reported Q2 revenue of 2.02 billion rupees, up from 1.83 billion rupees in the same period last year. The company's Q2 EBITDA increased to 818 million rupees from 760 million rupees year-over-year. However, the EBITDA margin declined to 40.6% compared to 41.54% in the previous year.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
3,182.60 | #1 26,458.80 | 49.01 | #1 2,554.80 | 11.28 | #1 492 | 16.36 | 54.29 | |
1,025.00 | #2 10,677.20 | #10 70.17 | #6 699.70 | #3 23.06 | #3 144 | #8 2.85 | 52.26 | |
1,929.00 | 10,269.80 | 64.70 | 1,346.30 | 10.64 | 146 | 13.28 | 41.99 | |
1,591.90 | 8,229.00 | 65.32 | 702.20 | 20.80 | 91 | 81.06 | 75.79 | |
813.80 | 2,682.00 | 31.75 | 742.70 | 16.70 | 78 | 22.45 | 53.37 | |
302.45 | 1,572.30 | 50.40 | 255.90 | 15.11 | 31 | -13.73 | 40.87 | |
1,348.90 | 1,139.90 | 23.16 | 111.60 | 28.72 | 48 | 0.67 | 47.29 | |
308.15 | 955.00 | #1 -104.65 | 1,170.80 | -18.47 | -134 | 90.05 | 56.22 | |
462.50 | 860.90 | 19.53 | 147.80 | #1 134.60 | 19 | #1 760.87 | 75.88 | |
143.00 | 102.80 | 62.28 | 41.80 | 13.28 | 2 | 100.00 | 43.00 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
23.06 %
Net Income Growth
20.23 %
Cash Flow Change
22.46 %
ROE
-0.77 %
ROCE
-1.44 %
EBITDA Margin (Avg.)
-1.98 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 234 | 301 | 482 | 541 | 714 | 853 | 983 | 1,274 |
| Fixed Assets | 119 | 151 | 272 | 268 | 371 | 524 | 742 | 865 |
| Current Assets | 103 | 138 | 186 | 239 | 270 | 276 | 211 | 307 |
| Capital Work in Progress | 3 | 3 | 10 | 9 | 34 | 28 | 9 | 70 |
| Investments | 73 | 69 | 55 | 28 | 54 | 139 | 109 | 185 |
| Other Assets | 39 | 78 | 146 | 236 | 255 | 163 | 123 | 154 |
| Total Liabilities | 234 | 301 | 482 | 541 | 714 | 853 | 983 | 1,274 |
| Current Liabilities | 40 | 50 | 59 | 44 | 66 | 66 | 73 | 163 |
| Non Current Liabilities | 33 | 40 | 150 | 138 | 178 | 241 | 250 | 312 |
| Total Equity | 161 | 211 | 274 | 359 | 470 | 547 | 660 | 799 |
| Reserve & Surplus | 155 | 204 | 270 | 355 | 458 | 535 | 647 | 786 |
| Share Capital | 5 | 5 | 5 | 5 | 10 | 10 | 10 | 10 |
Cash Flow
| Cash Flow | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -44 | -7 | 46 | -49 | 4 | 13 | -2 | -9 |
| Investing Activities | -98 | -90 | -31 | -130 | -123 | -110 | -141 | -182 |
| Operating Activities | 62 | 91 | 106 | 130 | 158 | 165 | 183 | 225 |
| Financing Activities | -8 | -7 | -30 | -49 | -31 | -42 | -45 | -52 |
Share Holding
| % Holding | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 60.00 % | 54.78 % | 54.78 % | 54.78 % | 55.04 % | 55.01 % | 55.01 % | 55.01 % | 54.98 % | 54.90 % | 54.87 % | 54.06 % | 53.93 % | 53.91 % | 53.91 % | 53.05 % | 52.63 % | 52.60 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 20.09 % | 20.08 % | 18.14 % | 17.54 % | 19.36 % | 19.56 % | 18.27 % |
| DIIs | 0.00 % | 14.09 % | 13.30 % | 12.88 % | 12.76 % | 15.28 % | 14.23 % | 13.90 % | 19.03 % | 17.99 % | 19.55 % | 20.80 % | 21.49 % | 23.46 % | 24.63 % | 23.72 % | 24.07 % | 25.34 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 5.45 % | 3.71 % | 3.82 % | 4.00 % | 4.97 % | 5.18 % | 5.13 % | 5.03 % | 5.06 % | 4.63 % | 4.38 % | 3.98 % | 3.94 % | 3.43 % | 3.42 % | 3.24 % | 3.20 % |
| Others | 40.00 % | 25.68 % | 28.21 % | 28.52 % | 28.20 % | 24.74 % | 25.58 % | 25.96 % | 20.96 % | 22.05 % | 20.95 % | 0.67 % | 0.52 % | 0.55 % | 0.49 % | 0.45 % | 0.50 % | 0.59 % |
| No of Share Holders | 7 | 2,34,724 | 82,139 | 79,021 | 77,229 | 76,985 | 79,059 | 76,532 | 73,850 | 72,795 | 66,204 | 66,724 | 62,415 | 62,258 | 60,952 | 66,891 | 62,115 | 58,994 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1 | 1 | 1 | 2 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.25 | 0.16 | 0.1 | 0.19 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 21 Sept 2022 |  Dividend | ₹ 1.00 /share | 20 Sept 2022 | 389.20 | 402.80 |
| 13 Sept 2023 | Dividend | ₹ 1.00 /share | 13 Sept 2023 | 376.05 | 473.60 |
| 30 Aug 2024 | Dividend | ₹ 1.00 /share | 30 Aug 2024 | 666.05 | 892.05 |
| 06 Sept 2024 |  Annual General Meeting | NA | 06 Sept 2024 | 819.80 | 947.20 |
| 07 Nov 2024 |  Quarterly Result Announcement | NA | 07 Nov 2024 | 934.40 | 980.25 |
| 12 Feb 2025 | Quarterly Result Announcement | NA | 12 Feb 2025 | 1,160.00 | 1,078.50 |
| 25 Apr 2025 |  Extraordinary General Meeting | NA | 25 Apr 2025 | 1,050.75 | 1,061.80 |
| 12 May 2025 | Quarterly Result Announcement | NA | 12 May 2025 | 1,018.20 | 993.10 |
| 28 Jul 2025 | Quarterly Result Announcement | NA | 28 Jul 2025 | 1,045.40 | 1,070.30 |
| 29 Aug 2025 | Dividend | ₹ 2.00 /share | 29 Aug 2025 | 993.10 | 993.45 |
| 05 Sept 2025 | Annual General Meeting | NA | 05 Sept 2025 | 1,050.00 | 1,089.40 |
| 04 Nov 2025 | Quarterly Result Announcement | NA | 04 Nov 2025 | 989.40 | 1,019.70 |
Announcements
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Nov 07, 2025
Nov 07, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 05, 2025
Nov 05, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 04, 2025
Nov 04, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 04, 2025
Nov 04, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 04, 2025
Nov 04, 2025Noting Of Wholly Owned Subsidiary - Medinova Millennium MRI Services LLP Pursuant To Scheme Of AmalgamationNov 04, 2025
Nov 04, 2025Announcement under Regulation 30 (LODR)-Scheme of ArrangementNov 04, 2025
Nov 04, 2025Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationNov 04, 2025
Nov 04, 2025Corporate Action - Fixation Of Record Date On November 25 2025.Nov 04, 2025
Nov 04, 2025Unaudited Financial Results For The Second Quarter And Half Year Ended September 30 2025.Nov 04, 2025
Nov 04, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On Nov 04 2025Nov 04, 2025
Nov 04, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 29, 2025
Oct 29, 2025Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Is Scheduled On 04/11/2025 Inter Alia To Consider And Approve The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Second Quarter And Half Year EOct 27, 2025
Oct 27, 2025Announcement under Regulation 30 (LODR)-Change in ManagementOct 18, 2025
Oct 18, 2025Announcement under Regulation 30 (LODR)-Scheme of ArrangementOct 18, 2025
Oct 18, 2025Announcement under Regulation 30 (LODR)-Scheme of ArrangementOct 16, 2025
Oct 16, 2025Shareholders Communication Relating To Saksham Niveshak CampaignOct 08, 2025
Oct 08, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 03, 2025
Oct 03, 2025Resignation Of Vice President - Operations (Mr. V. Siva Rama Raju Vegesna)Oct 01, 2025
Oct 01, 2025Announcement under Regulation 30 (LODR)-Scheme of ArrangementSep 29, 2025
Sep 29, 2025Closure of Trading WindowSep 25, 2025
Sep 25, 2025Rumour verification - Regulation 30(11)Sep 20, 2025
Sep 20, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 19, 2025
Sep 19, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 06, 2025
Sep 06, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 05, 2025
Sep 05, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2025
Aug 14, 2025Weblink Letter To Shareholders - As Per Regulation 36(1)(B) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 13, 2025
Aug 13, 2025Weblink Letter To Shareholders - As Per Regulation 36(1)(B) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 13, 2025
Aug 13, 2025Business Responsibility and Sustainability Reporting (BRSR)Aug 13, 2025
Aug 13, 2025Reg. 34 (1) Annual Report.Aug 13, 2025
Aug 13, 2025Notice Of The 23Rd Annual General Meeting (AGM) Of Vijaya Diagnostic Centre LimitedAug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 12, 2025
Aug 12, 2025Corporate Action - Record Date Friday 29Th August 2025 Fixed For Dividend PaymentAug 12, 2025
Aug 12, 2025Information Relating To 23Rd Annual General Meeting (AGM) Record Date And Cut-Off Date For E-Voting & AGM.Aug 12, 2025
Aug 12, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 04, 2025
Aug 04, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 02, 2025
Aug 02, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 29, 2025
Jul 29, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 28, 2025
Jul 28, 2025Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)Jul 28, 2025
Jul 28, 2025Announcement under Regulation 30 (LODR)-Investor PresentationJul 28, 2025
Jul 28, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 28, 2025
Jul 28, 2025Appointment Of Secretarial AuditorJul 28, 2025
Jul 28, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJul 28, 2025
Jul 28, 2025Board Meeting Outcome for Financial Results For The Quarter Ended June 30 2025Jul 28, 2025
Jul 28, 2025Financial Result For The Quarter Ended June 30 2025Jul 28, 2025
Jul 28, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 18, 2025
Jul 18, 2025Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30 2025.Jul 18, 2025
Jul 18, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 17, 2025
Jul 17, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 02, 2025
Jul 02, 2025Mutual Fund Holdings
Nippon India Multi Cap Fund Direct-Growth 
ICICI Prudential Flexicap Fund Direct - Growth 
Tata India Innovation Fund Direct-Growth 
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth 
Canara Robeco Value Fund Direct - Growth 
JioBlackRock Nifty Smallcap 250 Index Fund Direct - Growth 
Motilal Oswal Nifty Smallcap 250 Index Fund Direct - Growth 
HDFC Nifty Smallcap 250 Index Fund Direct-Growth 
SBI Nifty 500 Index Fund Direct-Growth 
Navi Nifty 500 Multicap 50:25:25 Index Fund Direct-Growth 
Kotak Nifty Smallcap 250 Index Fund Direct-Growth 
Groww Nifty Total Market Index Fund Direct - Growth 
Axis Nifty 500 Index Fund Direct-Growth 
Angel One Nifty Total Market Index Fund Direct - Growth 
Bandhan Nifty Total Market Index Fund Direct-Growth Technical Indicators
RSI(14)
Neutral 57.88
ATR(14)
Volatile 28.18
STOCH(9,6)
Neutral 74.31
STOCH RSI(14)
Overbought 86.90
MACD(12,26)
Bullish 5.70
ADX(14)
Weak Trend 10.33
UO(9)
Bearish 60.79
ROC(12)
Uptrend And Accelerating 3.20
WillR(14)
Neutral -28.11
About Vijaya Diagnostic Centre
Vijaya Diagnostic Centre Limited is an Indian company founded in 1981 and incorporated in 2002. It is the largest integrated diagnostic chain in South India, providing a comprehensive range of diagnostic services including pathological investigations, radiology, nuclear medicine, and related healthcare services. The company operates over 121 diagnostic centers across 20 cities in India, offering laboratory services, radiology and imaging, cardiology, neurology, and gastroenterology services. In 2021, Vijaya Diagnostic Centre Limited went public with an IPO of Rs 1895.04 crore and its shares were listed on the BSE and NSE.
Listing Date
14 Sept, 2021(4 Years,
5 days)
Chairperson NameSura Surendranath Reddy
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
